title: Inhalation of Alcohol Vapor: Measurement and Implications.
abstract: Decades of alcohol research have established the health risks and pharmacodynamic profile of oral alcohol consumption. Despite isolated periods of public health concern, comparatively less research has evaluated exposure to alcohol vapor. Inhaled alcohol initially bypasses first-pass metabolism and rapidly reaches the arterial circulation and the brain, suggesting that this route of administration may be associated with pharmacological effects that increase the risk of addiction. However, detailed reviews assessing the possible effects of inhaled alcohol in humans are lacking. A comprehensive, systematic literature review was conducted using Google Scholar and PubMed to examine manuscripts studying exposure to inhaled alcohol and measurement of biomarkers (biochemical or functional) associated with alcohol consumption in human participants. Twenty-one publications reported on alcohol inhalation. Fourteen studies examined inhalation of alcohol vapor associated with occupational exposure (e.g., hand sanitizer) in a variety of settings (e.g., naturalistic, laboratory). Six publications measured inhalation of alcohol in a controlled laboratory chamber, and 1 evaluated direct inhalation of an e-cigarette with ethanol-containing "e-liquid." Some studies have reported that inhalation of alcohol vapor results in measurable biomarkers of acute alcohol exposure, most notably ethyl glucuronide. Despite the lack of significantly elevated blood alcohol concentrations, the behavioral consequences and subjective effects associated with repeated use of devices capable of delivering alcohol vapor are yet to be determined. No studies have focused on vulnerable populations, such as adolescents or individuals with alcohol use disorder, who may be most at risk of problems associated with alcohol inhalation.
authors.affiliation: Department of Psychiatry, School of Medicine, Yale University, West Haven, Connecticut.|VA Connecticut Healthcare System, West Haven, Connecticut.
authors.forename: Robert Ross
authors.identifier: 0000-0001-8067-7828
authors.initials: RR
authors.lastname: MacLean
authors.affiliation: Department of Psychiatry, School of Medicine, Yale University, West Haven, Connecticut.|VA Connecticut Healthcare System, West Haven, Connecticut.
authors.forename: Gerald W
authors.initials: GW
authors.lastname: Valentine
authors.affiliation: Laboratory Medicine, Yale University, West Haven, Connecticut.
authors.forename: Peter I
authors.initials: PI
authors.lastname: Jatlow
authors.affiliation: Department of Psychiatry, School of Medicine, Yale University, West Haven, Connecticut.|VA Connecticut Healthcare System, West Haven, Connecticut.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Sofuoglu
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000428:Alcohol Drinking; D000818:Animals; D002492:Central Nervous System Depressants / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D066300:Electronic Nicotine Delivery Systems; D000431:Ethanol / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D000072137:Vaping
chemical_list: D002492:Central Nervous System Depressants; D000431:Ethanol
keywords: Alcohol Inhalation; Alcohol Without Liquid; Ethanol Vapor; Vaping; Vaportini